Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
SUPN
$42.38
+0.47%
SUPN
· Supernus Pharmaceuticals, Inc.
$42.38
+0.20 (+0.47%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.48B
Shares
58.13M
Volume · Oct 2
739.81K
Avg daily vol (3M)
777.92K
All webcasts
Earnings call · FY2026 Q2
Supernus Pharmaceuticals, Inc. (SUPN) Q2 2026 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$219.06M
+32.4% YoY
Diluted EPS
-$1.01
-352.5% YoY
Net income
-$58.37M
-359.4% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 22, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 3, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Aug 3, 2026 · complete as-filed document